Pfizer’s booster shots effective against Omicron variant: Israeli study
Category: #headlines  | By Nikita Chaurasia  | Date: 2021-12-13 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Pfizer’s booster shots effective against Omicron variant: Israeli study

Israeli researchers have reported that three shots of the Pfizer/BioNTech coronavirus vaccine provide considerable protection against the new Omicron variant.

The research was conducted by Central Virology Laboratory of the Health Ministry and Sheba Medical Centre. The study included a blood comparison of 20 people who had taken two vaccine doses 5-6 months earlier to the same number of individuals who had taken a booster shot a month ago.

Director of Sheba’s Infectious Diseases Unit, Gili Regev-Yochay, mentioned that people who had taken the second dose 5-6 months ago did not show any neutralization capacity against the Omicron variant, while they showed some against the Delta strain.

Regev-Yochay added that while the booster dose offers almost a hundred-fold increase in protection, it is still about four times less effective against Omicron as compared to the Delta variant.

The results were much like those presented by Pfizer and BioNTech early this week, which were a primary indication that booster shots could be important in offering protection against infection from the newly identified variant.

The Israeli team stated that it worked with the actual virus while the companies worked with what is known as a pseudo virus, which was bio-engineered to have the characteristic mutations of Omicron. The Israeli research builds on the study from South Africa that discovered that two doses are not effective enough against the new Omicron variant.

Despite reports confirming that the third shot of the Pfizer/BioNTech offering significant protection against Omicron, BioNTech has started working on a vaccine specifically targeting the Omicron variant in late November and could be out with a customized vaccine ready for distribution within 100 days.

Meanwhile, Israel announced restrictions banning its citizens from travelling to Denmark, Britain, and Belgium due to the spread of the new variant.  

The PM Naftali Bennett is reportedly being urged to impose stricter restrictions in Israel over the coming days.

 

Source Credit: https://www.dailymail.co.uk/news/article-10302089/Three-shots-Pfizer-vaccine-DOES-protect-against-Omicron-Israeli-study-shows.html

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

Dr. Reddy’s becomes India’s second biggest drugmaker by sales

By Nikita Chaurasia

Dr. Reddy's Laboratories Ltd. and Cipla Ltd. surpassed Aurobindo Pharma to rank as the 2nd and 3rd largest drug manufacturers in India by sales in the three months that ended on September 30. This was the first change in the pecking order of the ...

UK’s business confidence drops to its lowest point since 2009

UK’s business confidence drops to its lowest point since 2009

By Nikita Chaurasia

According to recent data, business confidence in the UK dropped to 18% in October, which was its lowest level in at least 13 years. In contrast, however, net balances of confidence stood at 28% in June and 56% in February, according to Accenture and ...

Attero aims to increase recycling capacity, plans for IPO in 2025

Attero aims to increase recycling capacity, plans for IPO in 2025

By Nikita Chaurasia

Attero Recycling, a firm that recycles electronic waste, is aiming to launch an initial public offering (IPO) in 2025, according to its Co-Founder and CEO Nitin Gupta. As per Gupta, the company is currently debating whether to list its shares in I...